17th International Conference on Biosimilars and Pharmaceuticals 2024

Future Prospects and Advancements of Biosimilars and Pharmaceuticals
Event Dates
2024-03-14 - 2024-03-15
Organizer
Exhibitors
25
Floor Size
0
Attendees
100
Event contact title
Contact
Event contact first name
General
Event contact last name
Queries
Email
pharma@scimeetings.com
Event contact telephone number
0044-2033180199
Description

The 17th International Conference on Biosimilars and Pharmaceuticals will be held on March 14-15, 2024 in London, UK. It focuses on the theme: "Future Prospects and Advancements of Biosimilars and Pharmaceuticals". Therefore this conference provides a superb chance to debate the most recent developments within the field.

Conference Series organizes over 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Pharmaceuticals, Biologics, Biosimilars, Health Care and Medical.

It covers a wide range of important sessions in  Biosimilars 2024 is a webinar which includes thought inspiring Keynote Presentations, Plenary Talks, Symposiums, Special Sessions and Career Development Programs.

This conference will cover the professionals gathering from Pharmacists, Health Care Professionals, Biologics, Biosimilars and Medical Professionals. Also executives and eminent research personalities from the departments of Pharmacists, Biosimilars, Biologics and Medical sectors etc. Shall be an integral part of this conference.

Partner Voices
MGM Resorts is committed to fostering an inclusive and diverse culture, not just among employees and guests but also within its supply chain. The company prioritizes procuring goods and services from businesses owned by minorities, women, veterans, people with disabilities, LGBTQ individuals and those facing economic disadvantages. This commitment is integral to MGM Resorts' global procurement strategy.    Through its voluntary supplier diversity program, MGM Resorts actively identifies and connects certified diverse-owned suppliers to opportunities within its supply chain. The company is on track to spend at least 15% of its biddable procurement with diverse-owned businesses by 2025, demonstrating that supplier diversity is not only a social responsibility but also a strategic business imperative.    Supplier diversity isn’t just the right thing to do – it’s good for business. A diverse supply chain allows access to a broader range of perspectives and experience, helping to drive innovation, entrepreneurship and resilience, while strengthening communities. At MGM Resorts, engaging diverse suppliers ensures best-in-class experiences for guests and clients. Supplier diversity ensures a more resilient supply chain while supporting economic development in the communities in which it operates.   The impact of MGM Resorts' supplier diversity initiatives is significant. In 2023, these efforts supported over 3,500 jobs across more than 30 states, contributed over $214 million in income for diverse-owned businesses and generated more than $62 million in tax revenue. The story extends beyond the numbers – it reflects the tangible benefits brought to small and diverse-owned businesses, fostering economic empowerment in their communities.    MGM Resorts also supports the development and business skills of diverse-owned businesses through investment, mentorship and education. Through the MGM Resorts Supplier Diversity Mentorship Program, the company identifies, mentors and develops diverse-owned businesses to fill its future pipeline, while providing businesses with tools and resources to empower and uplift. Since 2017, the program has successfully graduated 105 diverse-owned businesses and is on track to achieve its goal of 150 graduates by 2025.     MGM Resorts’ commitment to supplier diversity not only enhances its business operations but also plays a crucial role in uplifting communities and fostering economic development. This approach reinforces the idea that diversity is a powerful driver of innovation and resilience, benefiting both the company and the wider community.